Acorda Therapeutics is a biopharmaceutical company that identifies, develops, and commercializes novel therapies for neurological disorders in the United States. It specializes in drugs that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Its best known products are Zanaflex, Ampyra and Qutenza. Acorda Therapeutics was founded in 1995 and is headquartered in Ardsley, New York.